Britland, Stephen - University of Wolverhampton - Faculty of Science & Engineering

个人简介

Head of Wolverhampton School of Pharmacy (2013-) Associate Dean for Research and Post-graduate Studies, Faculty of Science and Engineering (2014-) Head of Pharmacology, Univ. of Bradford, UK (2008-2013) and Team Leader – Clinical Therapeutics, Univ. Bradford, UK (2011-2013) Reader in Cell Biology, Univ. Bradford, UK (2003-2013) Senior Lecturer in Pharmacology, Univ. Bradford (2001-2003) Lecturer in Pharmacology, Univ. Bradford (1997-2001) Research Fellow 1994-1997, Dept. of Electronics, Univ. Glasgow. Lecturer in Neuroscience 1990-1994, Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, University of London. (Awarded Recognised Teacher Status in Neuropathology 1993). Post-doctorate research assistant 1989-1990, Depts. of Electronics and Electrical Engineering and Cell Biology, University of Glasgow. Post-doctorate research assistant 1988-1989, Dept. of Anatomy, University of Aberdeen.

研究领域

Throughout my career the scope of my interests and outputs has been broad and included advanced microscopical techniques for interface imaging (funded by EPSRC), point-of-care diagnostics for chronic wound management (funded by TSB/AGT Sciences Ltd), in vitro pharmacological models of skin disease (funded by Reckitt Benckiser Ltd), mimetic cartilage replacement devices (funded by Yorkshire Forward/AGT Sciences Ltd), pulmonary drug delivery (White Rose Health Innovation Partnership), infection control (Industry/USA), magnetophoretic drug delivery (Industry/Australia), stem cell work (EPSRC/China Bridges) and lastly the area that has generated most media interest work on the biochemistry of Lucilia Serricata biotherapy in wound management and its application to biotechnology (TSB/DTI/AGTS sciences Ltd.). I’m currently working with the ‘ceutics team at Wolverhampton School of Pharmacy in the areas of drug delivery in wound management and pharmaceutical engineering applications for personalised medicine. Member of a NIHR Healthcare Technology Strategic Partnership. April 2012. Work Stream: Experience Based Co Design for wound care devices, technologies, technology-dependent interventions. Director: Professor Peter Vowden, BIHR, Bradford Royal Infirmary. Co- applicants: S. Britland Pharmacy Wolverhampton; J. Nixon and A. Nelson, Leeds University; P.Grocott and R. Glenn, King’s College London; J. Steven, Birmingham NHS Trust.

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Al-Ani, E., Hill, D.J., Britland, S.T., Amin, M.C.I.M and Martin, C. Mucoadhesive buccal tablets based on hydroxypropyl methylcellulose (HPMC) and poloxamer 407 (P407) for controlled delivery of chlorhexidine. Colloids and Surfaces B: Biointerfaces. Submitted June 2016. Gupta, A., Low, W.L., Radecka, I., Britland, S.T., Amin, M.C.I.M., and Martin, C. Development and characterisation of silver-loaded bacterial cellulose for antimicrobial hydrogel wound dressing applications. Journal of Microencapsulation accepted June 2016. Low, W.L., Kenward, M.A., Britland, S.T., Amin, M.C.I.M. and Martin, C. (2016). Essential oils and metal ions as alternative antimicrobial agents: A focus on tea tree oil and silver. International Wound Journal. In press. Available at http://dx.doi:10.1111/iwj.12611. Martin, C., Low, W.L., Gupta, A., Amin, M.C.I.M., Radecka, I., Britland, S.T., Raj, P. and Kenward, M.A. (2015). Strategies for Antimicrobial Drug Delivery to the Biofilm. Current Pharmaceutical Design, 21 (1): 43-66. Martin, C., Low, W. L., Gupta, A., Amin, M. C. I. M., Radecka, I., Britland, S T., Raj, P. and Kenward, M. A. (2015). Strategies for Antimicrobial Drug Delivery to the Biofilm. Current Pharmaceutical Design 21:43-66. Liposome encapsulated Disulfiram targets breast cancer stem cells in vitro and in vivo (2014) Peng Liu, Zhipeng Wang, Sarah Brown, Vinodh Kannappan, Patricia Erebi Tawari, Wenguo Jiang, Juan M. Irache, James Z. Tang, Stephen Britland, Angel L. Armesilla, John L. Darling, Xing Tang and Weiguang Wang. Oncotarget 5:7471-7486. Sensitivity and specificity of the empirical lymphocyte genome sensitivity (LGS) assay: implications for improving cancer diagnostics (2014). Anderson D, Najafzadeh N, Gopalan R, Ghaderi N, Scally A, Britland S, Jacobs B, Reynolds P, Davies J, Wright A, Al-Ghazal S, Sharpe D, Denyer M. FASEB (10):4563-70. Martin, C., Low, W. L., Gupta, A., Amin, M. C. I. M., Radecka, I., Britland, S. T., Raj, P., and Kenward, M. A. (2014). “Liposomal Delivery of Antimicrobials” in Advances in Liposome Research (part of the Biochemistry Research Trends series) edited by Laura Finney. Nova Science Publishers Inc., New York, pp 27 – 61. ISBN 978-1-63117-074-4.